Association of weight change after colorectal cancer diagnosis and outcomes in the kaiser permanente northern California population

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 1, 2017, Pages 30-37

  Meyerhardt, Jeffrey A ^a   Kroenke, Candyce H ^b   Prado, Carla M ^c   Kwan, Marilyn L ^b   Castillo, Adrienne ^b   Weltzien, Erin ^b   Feliciano, Elizabeth M Cespedes ^b   Xiao, Jingjie ^c   Caan, Bette J ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; CALIFORNIA; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER SURVIVAL; CLINICAL OUTCOME; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; SOCIAL STATUS; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; AGED; BODY WEIGHT GAIN; BODY WEIGHT LOSS; CANCER STAGING; COLORECTAL TUMOR; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; INSURANCE; KAPLAN MEIER METHOD; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL ANALYSIS; TUMOR INVASION; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CALIFORNIA; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; WEIGHT GAIN; WEIGHT LOSS; YOUNG ADULT;

EID: 85009070675     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0145     Document Type: Article

References (63)

1. Calle EE, Rodriguez C, Walker-Thurmond K, ThunMJ.Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
2. Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 2010;11:19-30.
3. Tartter PI, Slater G, Papatestas AE, Aufses AH Jr. Cholesterol, weight, height, Quetelet's index, and colon cancer recurrence. J Surg Oncol 1984;27:232-5.
4. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Benson AB III, Macdonald JS, et al. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003;98:484-95.
5. Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D, et al. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 2004;22:648-57.
6. Dignam JJ, Polite BN, Yothers G, Raich P, Colangelo L, O'Connell MJ, et al. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006;98:1647-54.
7. Meyerhardt JA, NiedzwieckiD, Hollis D, Saltz LB, Mayer RJ, NelsonH, et al. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 2008;26:4109-15.
8. Hines R, Shanmugam C, Waterbor J, McGwin G, Funkhouser E, Coffey C, et al. Effect of comorbidity and body mass index on the survival of African-American and caucasian patients with colon cancer. Cancer 2009;115: 5798-806.
9. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res 2010;16:1884-93.
10. Kuiper JG, Phipps AI, NeuhouserML, Chlebowski RT, Thomson CA, Irwin ML, et al. Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control 2012;23:1939-48.
11. Chin CC, Kuo YH, Yeh CY, Chen JS, Tang R, Changchien CR, et al. Role of body mass index in colon cancer patients in Taiwan. World J Gastroenterol 2012;18:4191-8.
12. Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM. Impact of body mass index on survival after colorectal cancer diagnosis: The Cancer Prevention Study-II Nutrition Cohort. JClin Oncol 2012;30:42-52.
13. Sinicrope FA, FosterNR, Yothers G, Benson A, Seitz JF, Labianca R, et al.Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 2013;119:1528-36.
14. Renehan AG. The 'obesity paradox' and survival after colorectal cancer: True or false? Cancer Causes Control 2014;25:1419-22.
15. Parkin E, O'Reilly DA, Sherlock DJ, Manoharan P, Renehan AG. Excess adiposity and survival in patients with colorectal cancer: A systematic review. Obes Rev 2014;15:434-51.
16. Otto SJ, Korfage IJ, Polinder S, van derHeide A, de Vries E, Rietjens JA, et al. Association of change in physical activity and body weight with quality of life and mortality in colorectal cancer: A systematic review and metaanalysis. Support Care Cancer 2015;23:1237-50.
17. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 2005;23:1370-8.
18. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change inwomen treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 1990;8:1327-34.
19. Fedele P, Orlando L, Schiavone P, Quaranta A, Lapolla AM, De Pasquale M, et al. BMI variation increases recurrence risk in women with early-stage breast cancer. Future Oncol 2014;10:2459-68.
20. Thivat E, Therondel S, Lapirot O, Abrial C, Gimbergues P, Gadea E, et al. Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse. BMC Cancer 2010;10:648.
21. Caan BJ, Emond JA, Natarajan L, Castillo A, Gunderson EP, Habel L, et al. Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer. Breast Cancer Res Treat 2006;99:47-57.
22. Caan BJ, KwanML, Hartzell G, Castillo A, Slattery ML, Sternfeld B, et al. Prediagnosis body mass index, post-diagnosis weight change, and prognosis among womenwith early stage breast cancer. Cancer Causes Control 2008; 19:1319-28.
23. Jeon YW, Lim ST, Choi HJ, Suh YJ. Weight change and its impact on prognosis after adjuvant TAC (docetaxel-doxorubicin-cyclophosphamide) chemotherapy in Korean women with node-positive breast cancer. Med Oncol 2014;31:849.
24. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990;1:43-6.
25. Baade PD, Meng X, Youl PH, Aitken JF, Dunn J, Chambers SK. The impact of body mass index and physical activity on mortality among patients with colorectal cancer in Queensland, Australia. Cancer Epidemiol Biomarkers Prev 2011;20:1410-20.
26. Cederholm TE, Bauer JM, Boirie Y, Schneider SM, Sieber CC, Rolland Y. Toward a definition of sarcopenia. Clin Geriatr Med 2011;27:341-53.
27. Rolland Y, Abellan van Kan G, Gillette-Guyonnet S, Vellas B. Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care 2011;14:15-21.
28. Fukushima H, Yokoyama M, Nakanishi Y, Tobisu K, Koga F. Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma. PLoS One 2015;10:e0115895.
29. Iritani S, Imai K, Takai K, Hanai T, Ideta T, Miyazaki T, et al. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol 2015;50:323-32.
30. Lanic H, Kraut-Tauzia J, Modzelewski R, Clatot F, Mareschal S, Picquenot JM, et al. Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy. Leuk Lymphoma 2014;55:817-23.
31. Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J, et al. Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 2015;22:2663-8.
32. Ozola Zalite I, Zykus R, Francisco Gonzalez M, Saygili F, Pukitis A, Gaujoux S, et al. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: A systematic review. Pancreatology 2015;15:19-24.
33. Parsons HA, Baracos VE, Dhillon N, Hong DS, Kurzrock R. Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service. PLoS One 2012;7:e29330.
34. Peng P, Hyder O, Firoozmand A, Kneuertz P, Schulick RD, Huang D, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 2012;16:1478-86.
35. Peng PD, van Vledder MG, Tsai S, de Jong MC, Makary M, Ng J, et al. Sarcopenia negatively impacts short-Term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB 2011;13:439-46.
36. Psutka SP, Carrasco A, Schmit GD, Moynagh MR, Boorjian SA, Frank I, et al. Sarcopenia in patients with bladder cancer undergoing radical cystectomy: impact on cancer-specific and all-cause mortality. Cancer 2014;120:2910-8.
37. Smith AB, Deal AM, Yu H, Boyd B, Matthews J, Wallen EM, et al. Sarcopenia as a predictor of complications and survival following radical cystectomy. J Urol 2014;191:1714-20.
38. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012;99:550-7.
39. Voron T, Tselikas L, Pietrasz D, Pigneur F, Laurent A, Compagnon P, et al. Sarcopenia impacts on short-And long-Term results of hepatectomy for hepatocellular carcinoma. Ann Surg 2015;261:1173-83.
40. Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J, et al. Negative impact of skeletal muscle loss after systemic chemotherapy in patients with unresectable colorectal cancer. PLoS One 2015;10:e0129742.
41. Barret M, Antoun S, Dalban C, Malka D, Mansourbakht T, Zaanan A, et al. Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer. Nutr Cancer 2014;66:583-9.
42. Roubenoff R. Physical activity, inflammation, and muscle loss. Nutr Rev 2007;65:S208-12.
43. Calvani R, Joseph AM, Adhihetty PJ, Miccheli A, Bossola M, Leeuwenburgh C, et al. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy. Biol Chem 2013;394:393-414.
44. Marzetti E, Calvani R, Cesari M, Buford TW, Lorenzi M, Behnke BJ, et al. Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol 2013;45:2288-301.
45. Guillet C, Boirie Y. Insulin resistance: A contributing factor to age-related muscle mass loss? Diabetes Metab 2005;31Spec No 2:5S20-5S6.
46. Kohara K. Sarcopenic obesity in aging population: current status and future directions for research. Endocrine 2014;45:15-25.
47. Srikanthan P, Hevener AL, Karlamangla AS. Sarcopenia exacerbates obesity-Associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III. PLoS One 2010; 5:e10805.
48. Sridhar SS, Goodwin PJ. Insulin-insulin-like growth factor axis and colon cancer. J Clin Oncol 2009;27:165-7.
49. Melstrom LG, Melstrom KA Jr, Ding XZ, Adrian TE. Mechanisms of skeletal muscle degradation and its therapy in cancer cachexia. Histol Histopathol 2007;22:805-14.
50. Smith KL, TisdaleMJ. Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer 1993; 67:680-5.
51. Je Y, Jeon JY, Giovannucci EL, Meyerhardt JA. Association between physical activity and mortality in colorectal cancer: A meta-Analysis of prospective cohort studies. Int J Cancer 2013;133:1905-13.
52. TsoliM, Schweiger M, Vanniasinghe AS, Painter A, Zechner R, Clarke S, et al. Depletion of white adipose tissue in cancer cachexia syndrome is associated with inflammatory signaling and disrupted circadian regulation. PLoS One 2014;9:e92966.
53. Murphy KT, Struk A, Malcontenti-Wilson C, Christophi C, Lynch GS. Physiological characterization of a mouse model of cachexia in colorectal liver metastases. Am J Physiol Regul Integr Comp Physiol 2013;304:R854-64.
54. Murphy RA, Wilke MS, Perrine M, Pawlowicz M, MourtzakisM, Lieffers JR, et al. Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clin Nutr 2010;29:482-7.
55. Kliewer KL, Ke JY, Tian M, Cole RM, Andridge RR, Belury MA. Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice. Cancer Biol Ther 2015;16:886-97.
56. Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr 2014;99:999-1005.
57. Bozorgmanesh M, Arshi B, Sheikholeslami F, Azizi F, Hadaegh F. No obesity paradox-BMI incapable of adequately capturing the relation of obesity with all-cause mortality: An inception diabetes cohort study. Int J Endocrinol 2014;2014:282089.
58. Cleary MP, Grossmann ME. Minireview: Obesity and breast cancer: The estrogen connection. Endocrinology 2009;150:2537-42.
59. Chan JA, Meyerhardt JA, Chan AT, Giovannucci EL, Colditz GA, Fuchs CS. Hormone replacement therapy and survival after colorectal cancer diagnosis. J Clin Oncol 2006;24:5680-6.
60. Lee J, Jeon JY, Meyerhardt JA. Diet and lifestyle in survivors of colorectal cancer. Hematol Oncol Clin North Am 2015;29:1-27.
61. Schlesinger S, Siegert S, Koch M, Walter J, Heits N, Hinz S, et al. Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: A prospective study and meta-Analysis. Cancer Causes Control 2014;25:1407-18.
62. Li XT, Tang L, Chen Y, Li YL, Zhang XP, Sun YS. Visceral and subcutaneous fat as new independent predictive factors of survival in locally advanced gastric carcinoma patients treated with neo-Adjuvant chemotherapy. J Cancer Res Clin Oncol 2015;141:1237-47.
63. Gordon NP. Similarity of the Adult Kaiser Permanente Membership in Northern California to the Insured and General Population in Northern California: Statistics from the 2011 California Health Interview Survey. Oakland (CA): Kaiser Permanente Division of Research; 2015 Jun. Available from: http://www.dor.kaiser.org/external/chis-non-kp-2011/.